ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Central nervous system management of pediatric acute lymphoblastic leukemia/lymphoblastic lymphoma

Central nervous system management of pediatric acute lymphoblastic leukemia/lymphoblastic lymphoma
This algorithm should be used in conjunction with related UpToDate topics. A diagnostic LP should be performed before or at the beginning of ALL/LBL treatment, whenever possible. Stratification of ALL/LBL risk and details of systemic and CNS-directed therapy vary among treatment groups and should be guided by the chosen treatment protocol. CNS management is administered through all phases of treatment. Patients with evidence of CNS involvement, based on neurologic findings or imaging results should be managed as per CNS 3. RT is generally not given, except for patients with CNS 3 status.

ALL/LBL: acute lymphoblastic leukemia/lymphoblastic lymphoma; WBC: white blood cell; Ph: Philadelphia chromsome/t(9;21) rearrangement; LP: lumbar puncture; CNS: central nervous system; IT: intrathecal; MTX: methotrexate; RT: radiation therapy; TLP: traumatic lumbar puncture.

* IT MTX or IT triple therapy, according to the chosen treatment protocol.

¶ The first IT treatment is generally given at the time of the initial diagnostic LP, but it may be delayed for patients with low-risk ALL/LBL with no lymphoblasts in peripheral blood.
Graphic 140219 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟